FDA greenlights Lilly’s EBGLYSS for ultra-low-frequency dosing in eczema breakthrough

The move makes EBGLYSS the only therapy offering as few as six maintenance injections per year

OET conducts Kerala workshop series to strengthen healthcare communication training

Three-city educator training programme equips teachers with practical strategies to improve healthcare English instruction and prepare professionals for global workforce demands

Novo Nordisk’s CagriSema delivers strong Phase 3 results across REIMAGINE diabetes trials

Pfizer reports strong mid-stage results for monthly GLP-1 drug berobenatide

The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format

Eli Lilly's oral weight-loss drug shows major fat loss across stages of menopause in trials

The results come from post-hoc analyses of more than 1,500 women enrolled in the Phase 3 ATTAIN-1 and ATTAIN-2 trials, presented at the American Diabetes Association’s 86th Scientific Sessions

FDA expands Pfizer’s HYMPAVZI approval

Broadening access for children & patients with inhibitor-complicated hemophilia

Manipal Hospital Dhakuria raises ovarian cancer awareness

The session created a platform for meaningful discussions on the challenges of the disease and the importance of timely intervention

Kunwar Khurana elevated to Head – Sales and Marketing at Dr. Reddy’s Labs

Seasoned pharmaceutical marketing leader brings extensive experience in brand management, sales strategy, and digital engagement to the expanded leadership role

Haleon invests Rs. 2000 crore to set up its first manufacturing facility in India

The greenfield facility in Madhya Pradesh expected to create up to 500 direct jobs, in addition to generating indirect employment opportunities

Shreehas Tambe appointed as new chairman of CII's National Pharmaceutical Committee

Amitabh Dube and Sheetal Arora named Co-Chairmen for the forthcoming term